| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
JC Polyoma Virus DNA, Quantitative, Real-Time PCR, Urine : 16446
Test CodeJCQNU or 16446
Alias/See Also
Polyomavirus, JCV Polyoma, JCV Viral Load, JC Virus DNA, QT Real-Time PCR
CPT Codes
87799
Transport Container
0.7 mL (0.3 mL minimum) Urine collected in sterile, leak-proof container
Transport Temperature
Frozen
Specimen Stability
Room temperature: 48 hours; Refrigerated 7 days; Frozen: 30 days
Methodology
Real-Time Polymerase Chain Reaction
Setup Schedule
Mon-Sat
Report Available
1-3 days
Limitations
Laboratory test results should always be considered in the context of clinical observations. This test was developed, and its performance characteristics determined by med fusion. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing.
Reference Range
Not Detected
Clinical Significance
JC Polyoma Virus is the cause of Progressive Multifocal Leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. PML is a particular concern for individuals infected with the human immunodeficiency virus. Quantification of JC virus DNA is based upon the real-time PCR amplification and detection of JCV genomic DNA. Reportable range is 50 to 50,000,000 IU/mL (1.70 to 7.70 Log IU/mL).
Performing Laboratory
med fusion
